Evaluation the Pharmacokinetics, Safety, Tolerability of TK001 in Patients With Neovascular Age-related Macular Degeneration
Clinical trial NCT02613559 · UNKNOWN
Trial details
- NCT number
- NCT02613559
- Sponsor
- Jiangsu T-Mab Biopharma Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2018-06-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.